Recruiting
Phase 1
Phase 2

Rinatabart Sesutecan (Rina-S) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

Sponsor:

Genmab

Code:

NCT05579366

Conditions

Platinum-Resistant Ovarian Cancer

Platinum Sensitive Ovarian Cancer (PSOC)

High Grade Epithelial Ovarian Cancer

High Grade Serous Ovarian Cancer

Primary Peritoneal Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Rina-S

Carboplatin

Bevacizumab

Pembrolizumab

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information